SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001062993-20-000263
Filing Date
2020-01-22
Accepted
2020-01-21 20:32:50
Documents
8
Period of Report
2020-01-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 16515
2 EXHIBIT 4.1 exhibit4-1.htm EX-4.1 48017
3 EXHIBIT 10.1 exhibit10-1.htm EX-10.1 373501
4 EXHIBIT 10.2 exhibit10-2.htm EX-10.2 111980
5 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 7672
6 GRAPHIC exhibit10-1x001.jpg GRAPHIC 2032
7 GRAPHIC exhibit4-1x001.jpg GRAPHIC 2032
8 GRAPHIC exhibit99-1xu001.jpg GRAPHIC 2493
  Complete submission text file 0001062993-20-000263.txt   568554
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38416 | Film No.: 20537402
SIC: 2834 Pharmaceutical Preparations